Dow Up0.76% Nasdaq Up0.69%

GlaxoSmithKline plc (GSK)

45.79 Up 0.43(0.95%) Oct 24, 4:02PM EDT
|After Hours : 45.86 Up 0.07 (0.15%) Oct 24, 7:51PM EDT
ProfileGet Profile for:
GlaxoSmithKline plc
980 Great West Road
Brentford, TW8 9GS
United Kingdom - Map
Phone: 44 20 8047 5000

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:99,451

Business Summary 

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company’s nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on GlaxoSmithKline plc

Key Executives 
Sir Andrew Philip Witty , 49
Chief Exec. Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
Mr. Simon Dingemans , 50
Chief Financial Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
Dr. Moncef M. Slaoui Ph.D., 54
Chairman of Global R&D & Vaccines, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
Mr. Daniel E. Troy ,
Sr. VP and Gen. Counsel
Mr. Philip C. Thomson ,
Sr. VP of Global Communications
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.